Valproate and valproic acid are not identical, but they are closely related forms of the same active drug. Valproic acid is the parent compound, a simple fatty acid. Sodium valproate is its sodium salt. Once you swallow either form, both break down in the gut and release the same active molecule: the valproate ion. So while the chemistry differs slightly on the pharmacy shelf, the substance working in your body is the same regardless of which form you take.
How the Forms Differ Chemically
Valproic acid is a small, eight-carbon fatty acid (technically 2-propylpentanoic acid). It has a carboxylic acid group that gives it its acidic properties, with a pKa of 4.8. At the pH inside your body, 99.8% of it sheds a hydrogen ion and becomes the valproate ion, which is the molecule that actually produces therapeutic effects.
Sodium valproate is simply that same molecule with a sodium atom attached in place of the hydrogen. Dissolve it in water, or expose it to stomach and intestinal fluids, and it separates into sodium and the valproate ion, the exact same active form produced by valproic acid.
There is also a third formulation called divalproex sodium, which combines sodium valproate and valproic acid in a 1:1 ratio. It was designed as a stable coordination compound that resists dissolving until it reaches the small intestine, which can reduce stomach irritation. All three, valproic acid, sodium valproate, and divalproex sodium, deliver the same valproate ion once absorbed.
Brand Names and What They Contain
The different chemical forms are sold under distinct brand names, which adds to the confusion:
- Depakene contains valproic acid as capsules (250 mg) or a syrup. The syrup actually delivers valproic acid in its sodium salt form.
- Depakote contains divalproex sodium as delayed-release tablets (125, 250, or 500 mg) or sprinkle capsules. Doses are labeled as the equivalent amount of valproic acid.
- Depakote ER is an extended-release version of divalproex sodium, available in 250 and 500 mg tablets.
- Depacon is sodium valproate in an intravenous form, used in hospitals when a patient can’t take pills.
Because all of these ultimately deliver the valproate ion, dosing across products is expressed in milligrams of valproic acid equivalent. A 500 mg Depakote tablet and a 500 mg Depakene capsule are considered bioequivalent. FDA review data confirm that the key measures of drug exposure (peak concentration and total absorption) fall within the standard bioequivalence range when comparing these products at the same dose.
How Absorption Speed Varies by Formulation
Although the active molecule is the same, the different formulations reach your bloodstream at very different speeds. This matters for side effects and how consistently blood levels stay in the therapeutic range.
Valproic acid syrup is the fastest, hitting peak blood concentration of about 34 mg/L in under an hour. Valproic acid capsules peak at roughly 31 mg/L around two hours. The delayed-release divalproex tablet has a built-in lag of about two hours before absorption even begins, peaking near 26 mg/L around 3.4 hours. Divalproex sprinkle capsules follow a similar pattern. The extended-release tablet is the slowest, reaching a much lower peak of about 12 mg/L at nearly 20 hours, spreading absorption across the full day.
Faster absorption means a sharper spike in blood levels, which can cause more nausea or sedation right after a dose. The delayed and extended-release formulations flatten that spike, which is one reason divalproex sodium was developed in the first place. The tradeoff is that the extended-release version has a lower peak, so dosing may need adjustment when switching between formulations.
Therapeutic Blood Levels
No matter which form you take, your doctor monitors the same blood test: total serum valproic acid. The generally accepted therapeutic range is 50 to 125 mcg/mL, measured as a trough level (the lowest point, usually drawn right before your next dose) up to peak. Staying within this window balances seizure control or mood stabilization against the risk of side effects. Levels above 125 mcg/mL increase the chance of toxicity, including tremor, confusion, and liver strain.
Pregnancy and Reproductive Risks
The reproductive warnings apply equally to every valproate formulation because the active molecule is the same. About 1 in 9 babies (11%) born to women taking valproate during pregnancy will have a birth defect. These can include spina bifida, cleft lip and palate, heart defects, limb malformations, and kidney or urinary tract abnormalities. Beyond structural birth defects, 3 to 4 out of every 10 children exposed in the womb may experience developmental problems: delayed walking and talking, lower intellectual ability compared to peers, poor language skills, or memory difficulties. Children exposed to valproate in utero also have higher rates of autism spectrum disorders.
More recent evidence has extended concern to fathers as well. In men who take valproate in the three months before conception, roughly 5 in 100 children may develop neurodevelopmental conditions. Valproate can also reduce male fertility, though this may reverse after stopping the drug or lowering the dose. Regulatory agencies now recommend that both men and women of reproductive age use effective contraception while on any valproate product, and that it only be prescribed when other treatments have failed.
When Switching Between Forms
If your prescription changes from one valproate product to another, the switch is usually straightforward because they are bioequivalent milligram for milligram. A 500 mg dose of valproic acid capsules delivers the same total drug exposure as a 500 mg divalproex delayed-release tablet. The main thing that changes is how quickly the drug enters your bloodstream. Moving from an immediate-release to an extended-release form, or vice versa, can shift when you feel side effects or when your blood levels peak. Your doctor may check a blood level after switching to make sure you’re still in the therapeutic range, especially if seizure control or mood stability is sensitive to small changes.